Fresenius SE & Co. KGaA (FRE.XETRA)
Exchange: XETRA
Currency: EUR
Price: 32.66 (Close)
Summary
52 Week range | 200d Moving Avg. | Beta |
26.69 – 47.60 | 39.30 | 1.27 |
Dividend | Dividend Yield | Ex-Dividend date |
0.92 | 2.82% | 2022-05-16 |
P/E Ratio | Latest EPS | DGR 3 years |
10.02 | 3.26 | 5.47% |
Undervalued
Low
High Volatility
High
Slow
Dividend Growth
Fast
Profile
Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs, including intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products used in the collection and processing of blood components, as well as in transfusion medicine. The Fresenius Helios segment operates 86 hospitals, 124 outpatient clinics, and 10 prevention centers. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Sector: | Industry: | |
Healthcare | Medical Care | |
Total ESG Score
26 – 23 percentile
Environment
7 – 7 percentile
Social
12 – 7 percentile
Governance
17 – 7 percentile
Controversy level
2
MSCI ESG-Rating
n.a.
see MSCI ESG rating explained
Dividend Safety Metrics
Latest EPS | 3.26 | |
Annual Payout | 0.92 | |
Payout Ratio | 28.22% | |
Dividend growth | 28 Years | |
Dividend Score | 84 | |
Dividend Coverage Ratio | 3.54 | |
Altman-Z score | 0.00 |
Fresenius SE & Co. KGaA (FRE.XETRA) Valuation
Fresenius SE & Co. KGaA’s current dividend yield of 2.82% is 56% above its 5-year average. The 5-year average dividend yield is 1.80% (see red-line in chart). This indicates the stock may be undervalued today.
Fresenius SE & Co. KGaA (FRE.XETRA) Performance
The chart below displays the total price return(%) of Fresenius SE & Co. KGaA for different periods:
Fresenius SE & Co. KGaA (FRE.XETRA) Total Return
The chart below displays the (CAGR) total return (%) including all dividends paid of Fresenius SE & Co. KGaA for different periods:
Dividend Scorecard
Dividend Yield (TTM) | Annual Payout | Payout Ratio | Dividend growth |
2.82 | 0.92 | 28.22% | 28 Years |
Dividend Growth Summary
3 Year Growth Rate (CAGR) | 5.47% |
5 Year Growth Rate (CAGR) | 9.86% |
10 Year Growth Rate (CAGR) | 11.74% |
Dividend Growth Rates History
Year | Payout Amount | Annual Payout Growth (YoY) |
---|---|---|
2021 | 0.880 | 4.8% |
2020 | 0.840 | 5.0% |
2019 | 0.800 | 6.7% |
2018 | 0.750 | 21.0% |
2017 | 0.620 | 12.7% |
2016 | 0.550 | 25.0% |
2015 | 0.440 | 4.8% |
2014 | 0.420 | 13.5% |
2013 | 0.370 | 15.6% |
2012 | 0.320 | 10.3% |
2011 | 0.290 | 16.0% |
2010 | 0.250 | 7.3% |
2009 | 0.233 | 5.9% |
2008 | 0.220 | 15.8% |
Fresenius SE & Co. KGaA (FRE.XETRA) Dividend Payment History